Lucha por sobrevivir, diabetes tipo 2 y obesidad

Fernández-Real, 2012, Innate immunity, insulin resistance and type 2 diabetes, Diabetologia, 55, 273, 10.1007/s00125-011-2387-y Fernández-Real, 2008, Innate immunity, insulin resistance and type 2 diabetes, Trends Endocrinol Metab, 19, 10, 10.1016/j.tem.2007.10.004 Fernández-Real, 2003, Insulin resistance and chronic cardiovascular inflammatory syndrome, Endocr Rev, 24, 278, 10.1210/er.2002-0010 Fernández-Real, 1999, Insulin resistance and inflammation in an evolutionary perspective: the contribution of cytokine genotype/phenotype to thriftiness, Diabetologia, 42, 1367, 10.1007/s001250051451 Pickup, 1998, Is type II diabetes mellitus a disease of the innate immune system?, Diabetologia, 41, 1241, 10.1007/s001250051058 Pickup, 2004, Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes, Diabetes Care, 27, 813, 10.2337/diacare.27.3.813 Neel, 1962, Diabetes mellitus: a thrifty genotype rendered detrimental by progress, Am J Hum Genet, 14, 353 Fernández-Real, 1997, The TNF-alpha gene Nco I polymorphism influences the relationship among insulin resistance, percent body fat, and increased serum leptin levels, Diabetes, 46, 1468, 10.2337/diabetes.46.9.1468 Fernández-Real, 2000, Interleukin-6 gene polymorphism and insulin sensitivity, Diabetes, 49, 517, 10.2337/diabetes.49.3.517 Fernández-Real, 2000, Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects, J Clin Endocrinol Metab, 85, 1334, 10.1210/jc.85.3.1334 Gubern, 2006, Natural antibiotics and insulin sensitivity: the role of bactericidal/permeability-increasing protein, Diabetes, 55, 216, 10.2337/diabetes.55.01.06.db05-1108 Esteve, 2006, Polymorphisms in the interleukin-6 receptor gene are associated with body mass index and with characteristics of the metabolic syndrome, Clin Endocrinol (Oxf), 65, 88, 10.1111/j.1365-2265.2006.02553.x Fernández-Real, 2006, Burden of infection and insulin resistance in healthy middle-aged men, Diabetes Care, 29, 1058, 10.2337/dc05-2068 Esteve, 2005, Dyslipidemia and inflammation: an evolutionary conserved mechanism, Clin Nutr, 24, 16, 10.1016/j.clnu.2004.08.004 Moreno-Navarrete, 2009, Decreased circulating lactoferrin in insulin resistance and altered glucose tolerance as a possible marker of neutrophil dysfunction in type 2 diabetes, J Clin Endocrinol Metab, 94, 4036, 10.1210/jc.2009-0215 Moreno-Navarrete, 2011, Antimicrobial-sensing proteins in obesity and type 2 diabetes: the buffering efficiency hypothesis, Diabetes Care, 34, S335, 10.2337/dc11-s238 Greenblum, 2012, Metagenomic systems biology of the human gut microbiome reveals topological shifts associated with obesity and inflammatory bowel disease, Proc Natl Acad Sci USA, 109, 594, 10.1073/pnas.1116053109 Turnbaugh, 2006, An obesity-associated gut microbiome with increased capacity for energy harvest, Nature, 444, 1027, 10.1038/nature05414 Turnbaugh, 2009, A core gut microbiome in obese and lean twins, Nature, 457, 480, 10.1038/nature07540 Esteve, 2011, Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance, Curr Opin Clin Nutr Metab Care, 14, 483, 10.1097/MCO.0b013e328348c06d